The volume of investment from venture capital and private equity firms into European HealthTech businesses in 2018 signals technology having reached an inflection point in dictating how we prevent illness and receive care.
Data scientists are optimistic about the opportunity to improve how new medicines are discovered; most traditional medical scientists (including most pharma researchers) are skeptical these new approaches will deliver benefit to patients, but convincib…
The longevity industry gets a boost with the launch of a $100 million venture fund, Longevity Vision Fund, focused on longevity biotechnology and artificial intelligence. The fund will invest in infrastructure projects enabling the longevity biotechnol…
I offer an evolving list of ideas that health care professionals need to better explain to their patients. Overcoming these common myths will be challenging given the growing diversity of media sources about health and wellness—but present an opportuni…
Life insurers in New York State can now use data from social media to set your premium rates and these rules could potentially extend beyond New York’s borders.